- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Panel Discussion On The Role Of Psychotherapy, Cognitive Training, & Digital Platforms For Treatment Of Major Depressive Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Panel Discussion On The Role Of Psychotherapy, Cognitive Training, & Digital Platforms For Treatment Of Major Depressive Disorder
Psychotherapy, particularly cognitive behavioral therapy, is a widely accepted and effective treatment approach for major depressive disorder.1 Cognitive training represents a promising and novel therapeutic intervention to address cognitive and affective symptoms of depression.2 Individual and systematic barriers may limit initiation and adherence to psychological interventions.3 Digital platforms may be one potential solution to improve access to treatment, lessen concerns about social stigma, and ease the cost burden.4 Our panel of experts will engage in an exciting discussion on the role of psychotherapy, cognitive training, and digital platforms for treatment of major depressive disorder.
References:
- Gelenberg AJ et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2010. Accessed on 3/4/2021 at: PG_Depression3e.book(PG_Depression_3e00Pre.fm) (psychiatryonline.org)
- Woolf, C., et al. Neuropsychol Rev. 2022 Jun; 32(2):419-437. A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder – PubMed (nih.gov)
- Mohr, D. C. et al. Journal of Clinical Psychology, 2010; 66(4): 394-409. And Lau Y et al. J Psychiatr Res. 2022;146:234–248.
- Wright JH, Mishkind M. Focus (Am Psychiatr Publ). 2020;18(2):162–168.

Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate for the School of Nursing at the University of Texas, Austin; Co-founder of WILD-5 Wellness®
More

Gaurava Agarwal, MD
Chief wellness executive, Northwestern Medicine Director of Faculty Wellness, Northwestern University
More

Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
More
Speakers Saundra Jain, MA, PsyD, LPCand Gaurava Agarwal, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Elizabeth DiNapoli, PhD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.